Liposome encapsulated hemoglobin as a resuscitation fluid for hemorrhagic shock

被引:0
作者
Usuba, A [1 ]
Osuka, F [1 ]
Kimura, T [1 ]
Sato, R [1 ]
Fujita, Y [1 ]
Yamashita, M [1 ]
Hoshino, C [1 ]
机构
[1] Fukushima Med Coll, Dept Surg 1, Fukushima 96012, Japan
关键词
artificial blood; blood substitute; oxygen carrier; liposome encapsulated hemoglobin; hemorrhagic shock; resuscitation fluid;
D O I
暂无
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The effectiveness of the blood substitute neo red cells (NRC) on hemorrhagic shock was evaluated in dogs. Shock was induced by bloodletting, and NRC was infused immediately until the dogs recovered from shock; the process was repeated 3 times (mild shock), or NRC was infused after shock was maintained for 30 min, and the process was repeated 3 times (severe shock). In mild shock, NRC with low viscosity reduced the peripheral vascular resistance and increased the cardiac index. However, in severe shock, only a slight decrease in the peripheral vascular resistance and no increase in the cardiac index were observed. In severe shock, the total oxygen consumption increased, but red blood cells or plasma did not change the oxygen transport and did not meet the increased oxygen demand. However, the NRC increased the oxygen transport and supplied the increased oxygen demand. In mild shock on the other hand, no increase was observed in the total oxygen consumption or the oxygen transport.
引用
收藏
页码:116 / 122
页数:7
相关论文
共 26 条
[1]  
BURK D, 1946, J BIOL CHEM, V165, P723
[2]   SURVIVAL OF MAMMALS BREATHING ORGANIC LIQUIDS EQUILIBRATED WITH OXYGEN AT ATMOSPHERIC PRESSURE [J].
CLARK, LC ;
GOLLAN, F .
SCIENCE, 1966, 152 (3730) :1755-&
[3]   PYRIDOXYLATED POLYMERIZED HEMOGLOBIN SOLUTION PROCESSING - INTEREST OF A MEMBRANE MOLECULAR FRACTIONATION STEP [J].
CLERC, Y ;
DUBOS, M ;
BIHOREAU, N ;
DELAMOURD, L ;
BRASSEUR, C ;
GOND, B ;
GOYFFON, M ;
SAINTBLANCARD, J .
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 1987, 14 (03) :241-251
[4]  
DJORDJEVICH L, 1980, EXP HEMATOL, V8, P584
[5]  
FARMER MC, 1987, METHOD ENZYMOL, V149, P184
[6]  
HONDA K, 1980, NEW ENGL J MED, V303, P391
[7]  
HONDA K, 1993, BIOMATER LIVING SYST, V1, P73
[8]   PREPARATION AND EVALUATION OF HEMOGLOBIN POLYETHYLENE-GLYCOL CONJUGATE (PYRIDOXALATED POLYETHYLENE-GLYCOL HEMOGLOBIN) AS AN OXYGEN-CARRYING RESUSCITATION FLUID [J].
IWASAKI, K ;
IWASHITA, Y .
ARTIFICIAL ORGANS, 1986, 10 (05) :411-416
[9]   FDA COMMITTEE QUESTIONS FLUOSOL EFFICACY - UNITED-STATES APPROVAL NOT IMMINENT [J].
MARWICK, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 250 (19) :2585-2586
[10]   CLINICAL-STUDIES OF A PERFLUOROCHEMICAL WHOLE-BLOOD SUBSTITUTE (FLUOSOL-DA) - SUMMARY OF 186 CASES [J].
MITSUNO, T ;
OHYANAGI, H ;
NAITO, R .
ANNALS OF SURGERY, 1982, 195 (01) :60-69